from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2958c/-

LFCtreatmentdescriptionclass of inhibitor

0.587

Amikacinug/mL Amikacintranslation

1.572

Cap5-10ug/mL Capreomycintranslation

1.046

Rox10-50 ug/mL Roxithromycintranslation

0.420

SM2-5 ug/mL Streptomycintranslation

1.136

Tet5-10 ug/mL Tetracyclinetranslation

0.036

Rif0.2-5ug/mL Rifampicintranscription

0.393

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.390

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.236

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.003

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.020

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.147

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.013

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.174

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.196

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.470

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.776

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.646

NaN30.2-2 mM Sodium aziderespiration

1.513

Nigericin50 uM Nigericinrespiration

-0.739

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

-0.630

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.430

menadione6-10 ug/mL Menadionerespiration

-0.085

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.634

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.883

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.034

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.658

NRP_1Non-replicating persistence stage 1dosRassociated

0.337

Amp0.2mg/mL AmpicillincellWall

-0.200

Cephalexin20-100 ug/mL CephalexincellWall

1.342

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.067

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.218

EMB10-20 ug/mL EthambutolcellWall

-0.148

Eta12-40 ug/mL EthionamidecellWall

0.200

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.235

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.576

BZA0.12 mg/mL BenzamidearomaticAmides

-0.244

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.619

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.356

H2O24 mM hydrogen peroxideDNAdamaging

1.069

Levo10 ug/mL LevofloxacinDNAdamaging

1.340

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.995

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.510

UVUV-irradiationDNAdamaging

0.632

ARP41-4 ug/mL Antitubercular compound ARP4?

0.702

Antimycin12.5-50 ug/mL Antimycin A?

-0.517

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.227

PA_110-50 ug/mL Antitubercular compound PA-1?

0.369

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.805

PA8240.2-2 ug/mL PA-824?

-0.990

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.702

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.554

Verapamil50 uM Verapamil?

-0.605

mercaptoethanol2 mM 2-Mercaptoethanol?

0.065

methoxatin10-20 ug/mL Methoxatin?